Literature DB >> 23280490

Tracheobronchial mycosis in a retrospective case-series study of five status asthmaticus patients.

Garbo Mak1, Paul C Porter, Venkata Bandi, Farrah Kheradmand, David B Corry.   

Abstract

The etiology of status asthmaticus (SA), a complication of severe asthma, is unknown. Fungal exposure, as measured by fungal atopy, is a major risk factor for developing asthma, but the relationship of fungi in SA per se has not previously been reported. In this five patient retrospective case series study, lower respiratory tract cultures were performed on bronchoalveolar lavage or tracheal aspirate fluid, comparing standard clinical laboratory cultures with a specialized technique in which respiratory mucus was removed prior to culture. We show that mucolytic treatment allows an increased detection of fungal growth, especially yeast, from the lower airways of all SA patients. We also demonstrate that inhalation of the yeast Candida albicans readily induces asthma-like disease in mice. Our observations suggest that SA may represent a fungal infectious process, and support additional prospective studies utilizing anti-fungal therapy to supplement conventional therapy, broad-spectrum antibiotics and high-dose glucocorticoids, which can promote fungal overgrowth.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23280490      PMCID: PMC3569972          DOI: 10.1016/j.clim.2012.11.005

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  25 in total

Review 1.  Clinical practice. Emergency treatment of asthma.

Authors:  Stephen C Lazarus
Journal:  N Engl J Med       Date:  2010-08-19       Impact factor: 91.245

2.  Effect of environmental molds on risk of death from asthma during the pollen season.

Authors:  P V Targonski; V W Persky; V Ramekrishnan
Journal:  J Allergy Clin Immunol       Date:  1995-05       Impact factor: 10.793

3.  Candida laryngotracheitis: a complication of combined steroid and antibiotic usage in croup.

Authors:  D M Burton; A B Seid; D B Kearns; S M Pransky
Journal:  Int J Pediatr Otorhinolaryngol       Date:  1992-03       Impact factor: 1.675

4.  Necessary and sufficient role for T helper cells to prevent fungal dissemination in allergic lung disease.

Authors:  Paul C Porter; Luz Roberts; Anna Fields; Morgan Knight; Yuping Qian; George L Delclos; Shuhua Han; Farrah Kheradmand; David B Corry
Journal:  Infect Immun       Date:  2011-08-29       Impact factor: 3.441

5.  Aspergillus species isolated from clinical specimens: suggested clinical and microbiological criteria to determine significance.

Authors:  Gilbert Greub; Jacques Bille
Journal:  Clin Microbiol Infect       Date:  1998-02       Impact factor: 8.067

6.  A prospective survey of Aspergillus spp. in respiratory tract samples: prevalence, clinical impact and antifungal susceptibility.

Authors:  K L Mortensen; H K Johansen; K Fuursted; J D Knudsen; B Gahrn-Hansen; R H Jensen; S J Howard; M C Arendrup
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-05-04       Impact factor: 3.267

7.  The diagnosis and incidence of allergic fungal sinusitis.

Authors:  J U Ponikau; D A Sherris; E B Kern; H A Homburger; E Frigas; T A Gaffey; G D Roberts
Journal:  Mayo Clin Proc       Date:  1999-09       Impact factor: 7.616

8.  Prospective study of the impact of broad-spectrum antibiotics on the yeast flora of the human gut.

Authors:  G Samonis; A Gikas; P Toloudis; S Maraki; G Vrentzos; Y Tselentis; N Tsaparas; G Bodey
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-08       Impact factor: 3.267

9.  Randomized controlled trial of oral antifungal treatment for severe asthma with fungal sensitization: The Fungal Asthma Sensitization Trial (FAST) study.

Authors:  David W Denning; B Ronan O'Driscoll; Georgina Powell; Fiona Chew; Graham T Atherton; Aashish Vyas; John Miles; Julie Morris; Robert M Niven
Journal:  Am J Respir Crit Care Med       Date:  2008-10-23       Impact factor: 21.405

10.  Chronic asthma and rhinitis due to Candida albicans, epidermophyton, and trichophyton.

Authors:  P Gumowski; B Lech; I Chaves; J P Girard
Journal:  Ann Allergy       Date:  1987-07
View more
  9 in total

Review 1.  Fungi in Mucoobstructive Airway Diseases.

Authors:  Evan Li; Cameron T Landers; Hui-Ying Tung; J Morgan Knight; Zachary Marshall; Amber U Luong; Antony Rodriguez; Farrah Kheradmand; David B Corry
Journal:  Ann Am Thorac Soc       Date:  2018-11

2.  Airway surface mycosis in chronic TH2-associated airway disease.

Authors:  Paul C Porter; Dae Jun Lim; Zahida Khan Maskatia; Garbo Mak; Chu-Lin Tsai; Martin J Citardi; Samer Fakhri; Joanne L Shaw; Annette Fothergil; Farrah Kheradmand; David B Corry; Amber Luong
Journal:  J Allergy Clin Immunol       Date:  2014-06-11       Impact factor: 10.793

Review 3.  Airway fibrinogenolysis and the initiation of allergic inflammation.

Authors:  Valentine Ongeri Millien; Wen Lu; Garbo Mak; Xiaoyi Yuan; J Morgan Knight; Paul Porter; Farrah Kheradmand; David B Corry
Journal:  Ann Am Thorac Soc       Date:  2014-12

4.  Selective cleavage of fibrinogen by diverse proteinases initiates innate allergic and antifungal immunity through CD11b.

Authors:  Cameron T Landers; Hui-Ying Tung; J Morgan Knight; Matthew C Madison; Yifan Wu; Zhimin Zeng; Paul C Porter; Antony Rodriguez; Matthew J Flick; Farrah Kheradmand; David B Corry
Journal:  J Biol Chem       Date:  2019-04-16       Impact factor: 5.157

5.  Computer-Assisted Analysis of Oral Antifungal Therapy in Chronic Rhinosinusitis with Airway Mycosis: a Retrospective Cohort Analysis.

Authors:  Evan Li; Michael Scheurer; Farrah Kheradmand; Amber U Luong; David B Corry
Journal:  Antimicrob Agents Chemother       Date:  2021-09-07       Impact factor: 5.191

6.  Candida albicans elicits protective allergic responses via platelet mediated T helper 2 and T helper 17 cell polarization.

Authors:  Yifan Wu; Zhimin Zeng; Yubiao Guo; Lizhen Song; Jill E Weatherhead; Xinyan Huang; Yuying Zeng; Lynn Bimler; Cheng-Yen Chang; John M Knight; Christian Valladolid; Hua Sun; Miguel A Cruz; Bernhard Hube; Julian R Naglik; Amber U Luong; Farrah Kheradmand; David B Corry
Journal:  Immunity       Date:  2021-09-09       Impact factor: 31.745

7.  Benefits of antifungal therapy in asthma patients with airway mycosis: A retrospective cohort analysis.

Authors:  Evan Li; Chu-Lin Tsai; Zahida K Maskatia; Ekta Kakkar; Paul Porter; Roger D Rossen; Sarah Perusich; John M Knight; Farrah Kheradmand; David B Corry
Journal:  Immun Inflamm Dis       Date:  2018-03-25

8.  Novel acute hypersensitivity pneumonitis model induced by airway mycosis and high dose lipopolysaccharide.

Authors:  Yuying Zeng; Yun Zhang; Xinyan Huang; Lizhen Song; Katherine Polsky; Yifan Wu; Farrah Kheradmand; Yubiao Guo; Linda K Green; David B Corry; John M Knight
Journal:  Respir Res       Date:  2021-10-10

9.  STAT6 Blockade Abrogates Aspergillus-Induced Eosinophilic Chronic Rhinosinusitis and Asthma, A Model of Unified Airway Disease.

Authors:  Hua Sun; Ashish Damania; Megan L Mair; Eniola Otukoya; Yi-Dong Li; Katherine Polsky; Yuying Zeng; Jeremiah A Alt; Martin J Citardi; David B Corry; Amber U Luong; John Morgan Knight
Journal:  Front Immunol       Date:  2022-02-23       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.